AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis

PHASE2UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

May 31, 2011

Study Completion Date

March 31, 2012

Conditions
Secondary Progressive Multiple Sclerosis
Interventions
DRUG

Hyperimmune caprine serum against HIV lysate

1.0ml solution for subcutaneous injection (4.5mg total protein / ml) twice weekly for 4 weeks

Trial Locations (1)

NW3 2QG

Royal Free Hospital Hampstead NHS Trust, London

Sponsors
All Listed Sponsors
lead

Daval International Limited

INDUSTRY

NCT01228396 - AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis | Biotech Hunter | Biotech Hunter